207_Combined course Presentations

First page Table of contents Previous page 185 Next page Last page

Co-stimulatory molecules, treatments in development

Name

Treatment

CD28:CD80/86

TAB08

CD27:CD70

Varilumab

CD40:CD40L

CP870, 893, ChiLob7/4

OX40:OX40L

MEDI0562, 6469, 6383, MOXR0916

GITR:GITRL

TRX518 GWN323 MEDI1873 INCAGN01876

CD137: CD137L

Urelumab, PF-05082566